The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: fludara     Quarter: 2016Q3

Total Records: 529     Number of Pages: 27

DRUGNAME PT EventCount
FLUDARABINE Transplant failure 3
FLUDARABINE Tumour lysis syndrome 3
FLUDARABINE Venoocclusive disease 3
FLUDARABINE Venoocclusive liver disease 3
FLUDARABINE PHOSPHATE. Acute kidney injury 3
FLUDARABINE PHOSPHATE. Ascites 3
FLUDARABINE PHOSPHATE. Bacteraemia 3
FLUDARABINE PHOSPHATE. Brain oedema 3
FLUDARABINE PHOSPHATE. Dyspnoea 3
FLUDARABINE PHOSPHATE. Infection 3
FLUDARABINE PHOSPHATE. Jaundice 3
FLUDARABINE PHOSPHATE. Oedema peripheral 3
FLUDARABINE PHOSPHATE. Pneumonia 3
FLUDARABINE PHOSPHATE. Product use issue 3
FLUDARABINE PHOSPHATE. Respiratory failure 3
FLUDARABINE PHOSPHATE. Rotavirus infection 3
FLUDARA Acute lymphocytic leukaemia 2
FLUDARA Acute respiratory failure 2
FLUDARA Adenovirus infection 2
FLUDARA Ascites 2

Total Records: 529     Number of Pages: 27